Amass

Amass

Direct-to-consumer premium botanics and gifting

Overview

AMASS is a premium botanics brand that targets the wellness and luxury goods markets. It offers a range of plant-based products including Dry Gin, Botanic Vodka, personal care items, candles, and bath salts, sold chiefly through its website and via corporate gifting services. The products work by using thoughtfully chosen botanicals and vegan, gluten-free formulations to support daily self-care and rituals. Unlike many competitors, AMASS combines high-quality botanical ingredients with a direct-to-consumer model and a dedicated corporate gifting program, emphasizing plant-powered wellness within a luxurious lifestyle context. The company’s goal is to provide sophisticated, plant-based products that enhance well-being and everyday rituals for individual customers and corporate clients alike.

About Amass

Simplify's Rating
Why Amass is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Consumer Goods

Company Size

51-200

Company Stage

Early VC

Total Funding

$3.5M

Headquarters

Los Angeles, California

Founded

2018

Get referred to Amass

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 1, 2026 powder mixers expand AMASS beyond cans into portable stick packs.
  • July 16, 2026 Tonic and Transfusion broaden flavors after $36,000 first-month revenue.
  • Afterdream distributed in seven states offers cross-category growth beyond legacy spirits.

What critics are saying

  • Nasdaq warned AMASS on July 22, 2026 for missing $50 million market-value thresholds.
  • The May 20, 2026 direct listing raised no capital, leaving balance-sheet strain unresolved.
  • March 31, 2026 revenue was $4.15 million against a $3.04 million net loss; going-concern doubt persists.

What makes Amass unique

  • AMASS sells both alcoholic and zero-proof beverages under one premium botanicals platform.
  • Its May 2026 electrolyte mixers pair hydration, mixer utility, and clean-label positioning.
  • Afterdream gives AMASS exposure to hemp-THC beverages and functional relaxation.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$3.5M

Above

Industry Average

Funded Over

1 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!
Early VC Funding Comparison
Coming Soon

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-1%
Associated Press
Jul 16th, 2026
AMASS electrolyte mixers hit $429K annual run rate in month one, launches Tonic and Transfusion flavours

AMASS Brands Group launched two limited edition flavors in its electrolyte mixers line: Tonic and Transfusion. The ready-to-drink products are now available through the company's direct-to-consumer channel. In its first full month following a May 2026 debut, the AMASS Electrolyte Mixers line generated approximately $36,000 in gross revenue across direct-to-consumer and wholesale channels, representing a $429,000 annualized run rate. Both new flavors contain essential electrolytes and Pacific sea salt, with significantly reduced sugar compared to leading competitors. AMASS Tonic has 82% less sugar than leading tonic water mixers, whilst AMASS Transfusion contains 66% less sugar than its competitor. The products are formulated without artificial sweeteners, colours, or flavours, and are non-GMO, vegan, and gluten-free. They can be consumed as standalone beverages or mixers with alcoholic or non-alcoholic spirits.

Yahoo Finance
Jun 24th, 2026
AMASS Brands invests in hemp-derived THC beverage maker Afterdream for 15.67% stake

AMASS Brands Group has entered into a Simple Agreement for Future Equity investment in Afterdream, a hemp-derived THC beverage brand, securing rights to at least a 15.67% fully diluted ownership stake. Afterdream produces non-alcoholic beverages with organic lion's mane mushrooms and L-Theanine, currently distributed across seven US states and over 100 accounts nationally. The brand has shown strong direct-to-consumer performance, with returning customer rates reaching 42% year-to-date and gross sales rising 43% over 90 days. The SAFE investment does not immediately issue shares and will convert into equity after a future qualifying financing event. AMASS CEO Mark Thomas Lynn said the investment positions the company at the forefront of the growing hemp-derived THC beverage category.

Minichart
Jun 24th, 2026
AMASS Brands raises $1.43M via SAFE with $7.5M valuation cap, files amendment to terms

AMASS Brands has invested $1.43 million in AfterDream via a Simple Agreement for Future Equity with a $7.5 million post-money valuation cap. The company subsequently executed a First Amendment confirming the valuation cap and conversion terms remain unchanged. The SAFE will convert into preferred stock upon an equity financing, liquidity event or dissolution. Conversion occurs at the lower of the valuation cap price or the price paid by new investors in future financing rounds. SAFE holders receive liquidation preference over common stock but rank equally with other preferred stockholders. The investment introduces potential dilution for existing shareholders and establishes a valuation benchmark for future fundraising. The SAFE does not confer voting rights until conversion, and the investor must be accredited under Regulation D.

Yahoo Finance
May 27th, 2026
Good Twin becomes US's #1 organic non-alcoholic wine brand with 122% sales growth

AMASS Brands Group announced that Good Twin has become the top organic non-alcoholic wine brand in the US by dollar share, according to Nielsen. The brand now holds 35.43% of the organic non-alcoholic wine category, gaining 12.93 share points year-over-year. Good Twin's dollar sales increased 122% year-over-year, whilst volume grew 115%, significantly outperforming the organic non-alcoholic wine category's 41.1% growth. The brand ranks among the top 10 non-alcoholic wine brands by sales volume in the US. AMASS Brands Group, which trades on Nasdaq under the ticker AMSS, operates a multi-category beverage platform spanning non-alcohol, functional and alcohol 2.0 products. The company's portfolio also includes Summer Water Rosé, the number-one selling premium domestic rosé in the US.

Renaissance Capital
May 20th, 2026
AMASS Brands completes Nasdaq direct listing at $16 expected reference price

AMASS Brands, a US-focused premium beverage company managing alcoholic and zero-proof brands, has completed a direct listing on the Nasdaq under the symbol AMSS. Existing shareholders plan to sell up to 14.3 million shares, with the company not raising new capital. The company disclosed an expected reference price of $16 per share, implying a market value of approximately $134 million. In December 2025, AMASS raised $261,856 in a crowdfunding round at $8.98 per share. AMASS distributes spirits, wine and non-alcoholic alternatives through wholesale, on-premise and direct-to-consumer channels. Its portfolio includes Good Twin Non-Alcoholic Wine, Summer Water Rosé and Calirosa Tequila. In 2023, the company acquired assets from Winc, a 2021 IPO. Maxim Group served as financial adviser on the listing.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Amass right now.

Find jobs on Simplify and start your career today

We update Amass's jobs every few hours, so check again soon! Browse all jobs →